US BANCORP \DE\

Bank

Position in CABA — Cabaletta Bio, Inc.

CIK 36104 MINNEAPOLIS, MN

Position in CABA

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$51,293

+$50,392 QoQ

Shares Held

16,493

+8535.1% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#102

of 139 holders

Holding Since

Jun 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

US BANCORP \DE\ holds $82,066,335 across 213 Biotechnology names. CABA ranks #81 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc.	66,580	$16,296,786
2	VRTX	Vertex Pharmaceuticals Inc / Ma	32,020	$15,905,293
3	TECH	BIO-TECHNE Corp	137,966	$9,747,297
4	REGN	Regeneron Pharmaceuticals, Inc.	5,330	$3,323,466
5	ARGX	Argenx SE	3,495	$3,242,555
6	ARWR	Arrowhead Pharmaceuticals, Inc.	38,226	$3,115,799
7	JAZZ	Jazz Pharmaceuticals plc	10,103	$2,434,518
8	GMAB	Genmab A/S	88,420	$2,428,896

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$51,293	16,493	+8535.1%	Shares	Defined	2026-08-12
2024-09-30	$901	191	-54.2%	Shares	Defined	2024-10-28
2024-06-30	$3,119	417	+52.2%	Shares	Defined	2024-08-07
2024-03-31	$4,674	274	0.0%	Shares	Defined	2024-05-08
2023-12-31	$6,219	274	-69.6%	Shares	Defined	2024-02-09
2021-09-30	$10,944	900	0.0%	Shares	Defined	2021-11-10
2021-06-30	$7,740	900	0.0%	Shares	Defined	2021-08-05
2021-03-31	$9,990	900	0.0%	Shares	Defined	2021-04-28
2020-12-31	$11,232	900	0.0%	Shares	Defined	2021-02-04
2020-09-30	$9,756	900	+200.0%	Shares	Defined	2020-11-10
2020-06-30	$3,342	300	—	Shares	Defined	2020-08-07
No filing history on record for this holder in this stock.